Evidence map›Paper›PMID 27646803›Full record

ArticleTranslational behavioral medicine2016

Society of Behavioral Medicine supports implementation of high quality lung cancer screening in high-risk populations.

Karriem S Watson, Amanda C Blok, Joanna Buscemi, Yamile Molina, Marian Fitzgibbon, Melissa A Simon, Lance Williams, Kameron Matthews, Jamie L Studts, Sarah E Lillie and 3 more

Open access · greenAbstract read
In one paragraph

Article in Translational behavioral medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Karriem S WatsonUniversity of Illinois Cancer Center, Chicago, IL, USA. kswatson@uic.edu.
Amanda C BlokUniversity of Massachusetts Medical School, Worcester, MA, USA.
Joanna BuscemiUniversity of Illinois Cancer Center, Chicago, IL, USA.
Yamile MolinaUniversity of Illinois Cancer Center, Chicago, IL, USA.
Marian FitzgibbonUniversity of Illinois Cancer Center, Chicago, IL, USA.
Melissa A SimonNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Lance WilliamsNortheastern Illinois University, Chicago, IL, USA.
Kameron MatthewsUniversity of Illinois Cancer Center, Chicago, IL, USA.
Jamie L StudtsUniversity of Kentucky College of Medicine, Lexington, KY, USA.
Sarah E LillieMinneapolis Veterans Affairs Hospital, Minneapolis, MN, USA.
Jamie S OstroffMemorial Sloan Kettering Cancer Center, New York City, NY, USA.
Lisa Carter-HarrisIndiana University School of Nursing, Indianapolis, IN, USA.
Robert A WinnUniversity of Illinois Cancer Center, Chicago, IL, USA.
University of Illinois Chicago · USUniversity of Illinois Hospital & Health Sciences System · USIndiana University – Purdue University Indianapolis · USIndo-American Center · USMemorial Sloan Kettering Cancer Center · USNortheastern Illinois University · USUniversity of Kentucky · USUniversity of Massachusetts Chan Medical School · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Research Education CoreU54CA202997 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CIECIERSKI, CHRISTINA, FEINGLASS, JOSEPH M · 2015 to 2024
$13.8M
Research Education CoreU54CA203000 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIECIERSKI, CHRISTINA, FEINGLASS, JOSEPH M · 2015 to 2024
$12.4M
The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)U54CA202995 · NCI · NORTHEASTERN ILLINOIS UNIVERSITY · PI CIECIERSKI, CHRISTINA · 2015 to 2024
$9.5M
Training & Education CoreP20CA202908 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MATTHEWS, ALICIA K · 2015 to 2018
$858k
Empowering Latinas to Obtain Breast Cancer ScreeningsK01CA193918 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MOLINA, YAMILE · 2016 to 2020
$729k
Development and feasibility testing of a lung cancer screening decision aidR21CA173880 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BYRNE, MARGARET M, STUDTS, JAMIE L · 2014 to 2015
$372k
NCI NIH HHS K01 CA193918NCI NIH HHS P20 CA202908NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA060553NCI NIH HHS R21 CA173880NCI NIH HHS U54 CA202995NCI NIH HHS U54 CA202997NCI NIH HHS U54 CA203000
6 · The paper itself

Abstract

The Society of Behavioral Medicine (SBM) supports the United States Preventive Services Task Force (USPSTF) recommendation of low-dose computed tomography (LDCT) screening of the chest for eligible populations to reduce lung cancer mortality. Consistent with efforts to translate research findings into real-world settings, SBM encourages health-care providers and health-care systems to (1) integrate evidence-based tobacco treatment as an essential component of LDCT-based lung cancer screening, (2) examine the structural barriers that may impact screening uptake, and (3) incorporate shared decision-making as a clinical platform to facilitate consultations and engagement with individuals at high risk for lung cancer about the potential benefits and harms associated with participation in a lung cancer screening program. We advise policy makers and legislators to support screening in high-risk populations by continuing to (1) expand access to high quality LDCT-based screening among underserved high-risk populations, (2) enhance cost-effectiveness by integrating evidence-based tobacco treatments into screening in high-risk populations, and (3) increase funding for research that explores implementation science and increased public awareness and access of diverse populations to participate in clinical and translational research.

Indexed as

Behavioral MedicineAgedAged, 80 and overAwarenessCost-Benefit AnalysisDecision MakingFemaleHealth PersonnelHumansLung NeoplasmsMaleMass ScreeningMiddle AgedSmoking CessationSocietiesTomography, X-Ray ComputedLung cancerPolicyScreeningShared decision-making

Identifiers

PMID27646803
PMCPMC5110503
OpenAlexW2523522594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.